Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA submission is ...

Given the serious financial and reputational risks of incidents that grind business to a halt, organizations need to prioritize a prevention-first cybersecurity strategy Under lock and key: ...

The University of Chicago's joint-degree program in law and business places students at the intersection of legal and business expertise. By offering both a three-year accelerated JD/MBA and a ...